A Study of KF-0210 in Advanced Solid Tumors Patients
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
The purpose of this Phase I, Multi-Center, Open-Label Study is to evaluate the safety, tolerability, Pharmacokinetics, Pharmacodynamics and anti-tumor activity of KF-0210 in participants with advanced solid tumors. The study will be conducted in two parts: phase Ia, and phase Ib.
创建时间：
2021-03-15
